CN1826110B - 用于口服施用紫杉烷类的半固体制剂 - Google Patents

用于口服施用紫杉烷类的半固体制剂 Download PDF

Info

Publication number
CN1826110B
CN1826110B CN2004800207228A CN200480020722A CN1826110B CN 1826110 B CN1826110 B CN 1826110B CN 2004800207228 A CN2004800207228 A CN 2004800207228A CN 200480020722 A CN200480020722 A CN 200480020722A CN 1826110 B CN1826110 B CN 1826110B
Authority
CN
China
Prior art keywords
formulations
taxanes
taxane
drug
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2004800207228A
Other languages
English (en)
Chinese (zh)
Other versions
CN1826110A (zh
Inventor
T·博罗瓦兹
C·尼夫斯
M-T·佩拉基亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of CN1826110A publication Critical patent/CN1826110A/zh
Application granted granted Critical
Publication of CN1826110B publication Critical patent/CN1826110B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2004800207228A 2003-07-18 2004-07-15 用于口服施用紫杉烷类的半固体制剂 Expired - Fee Related CN1826110B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03291795A EP1498120A1 (en) 2003-07-18 2003-07-18 Semi-solid formulations for the oral administration of taxoids
EP03291795.7 2003-07-18
PCT/EP2004/008551 WO2005013968A1 (en) 2003-07-18 2004-07-15 Semi-solid formulations for the oral administration of taxoids

Publications (2)

Publication Number Publication Date
CN1826110A CN1826110A (zh) 2006-08-30
CN1826110B true CN1826110B (zh) 2010-05-12

Family

ID=33462258

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800207228A Expired - Fee Related CN1826110B (zh) 2003-07-18 2004-07-15 用于口服施用紫杉烷类的半固体制剂

Country Status (20)

Country Link
US (1) US20050070496A1 (enExample)
EP (2) EP1498120A1 (enExample)
JP (1) JP5116306B2 (enExample)
KR (1) KR101143341B1 (enExample)
CN (1) CN1826110B (enExample)
AR (1) AR045996A1 (enExample)
AT (1) ATE388701T1 (enExample)
AU (1) AU2004262496B2 (enExample)
BR (1) BRPI0412759A (enExample)
CA (1) CA2532667A1 (enExample)
DE (1) DE602004012413T2 (enExample)
DK (1) DK1648440T3 (enExample)
ES (1) ES2303642T3 (enExample)
IL (1) IL173110A (enExample)
IN (1) IN229997B (enExample)
MX (1) MX260260B (enExample)
MY (1) MY137965A (enExample)
PT (1) PT1648440E (enExample)
TW (1) TWI342774B (enExample)
WO (1) WO2005013968A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
CA2652926A1 (en) * 2006-05-26 2007-12-06 Bayer Healthcare Llc Drug combinations with substituted diaryl ureas for the treatment of cancer
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
FR2924024B1 (fr) 2007-11-27 2012-08-17 Centre Nat Rech Scient Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse
FR2931152B1 (fr) * 2008-05-16 2010-07-30 Centre Nat Rech Scient Nouveau systeme de transfert d'acide nucleique
MX336339B (es) 2009-10-29 2016-01-14 Aventis Pharma Sa Nuevo uso antitumoral de cabazitaxel.
PH12012502163A1 (en) 2010-05-03 2017-07-28 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103980232A (zh) * 2014-06-05 2014-08-13 北京诺普德医药科技有限公司 10-乙酰基多西紫杉醇及其用途
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
CN113698369A (zh) * 2021-08-31 2021-11-26 无锡紫杉药业有限公司 一种除去卡巴他赛中特定单杂的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
US5478854A (en) * 1992-10-01 1995-12-26 Bristol-Myers Squibb Company Deoxy taxols
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
AU756752B2 (en) * 1998-04-01 2003-01-23 Skyepharma Canada Inc. Anticancer compositions
AU5273200A (en) * 1999-05-24 2000-12-12 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
JP2004520398A (ja) * 2001-01-18 2004-07-08 ファルマシア・アンド・アップジョン・カンパニー 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物
AU2002357012A1 (en) * 2001-11-27 2003-06-10 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
WO2003053350A2 (en) * 2001-12-20 2003-07-03 Bristol-Myers Squibb Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
ES2283756T3 (es) * 2002-03-01 2007-11-01 Novagali Pharma Sa Sistemas autoemulsionantes de administracion de farmaco para taxoides.
KR20090072980A (ko) * 2007-12-28 2009-07-02 서울옵토디바이스주식회사 발광 다이오드 및 그 제조방법

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ADAMS M W.International Congress of Technology and Pharmacology.1992,第261页第4段. *
MU L 等.A novel controlled relese formulation for the anticancer drugpaclitaxel(Taxol<(>R)):PLGA nanoparticles containing vitaminE TPGS.Journal of Controlled Release86 1.2003,86(1),摘要，34，36.
MU L 等.A novel controlled relese formulation for the anticancer drugpaclitaxel(Taxol<(>R)):PLGA nanoparticles containing vitaminE TPGS.Journal of Controlled Release86 1.2003,86(1),摘要,34,36. *

Also Published As

Publication number Publication date
DE602004012413D1 (de) 2008-04-24
TW200517104A (en) 2005-06-01
CN1826110A (zh) 2006-08-30
AU2004262496B2 (en) 2009-02-05
TWI342774B (en) 2011-06-01
KR20060037370A (ko) 2006-05-03
EP1648440A1 (en) 2006-04-26
AU2004262496A1 (en) 2005-02-17
HK1091743A1 (zh) 2007-01-26
MXPA06000636A (es) 2006-04-19
IL173110A0 (en) 2006-06-11
ES2303642T3 (es) 2008-08-16
JP5116306B2 (ja) 2013-01-09
PT1648440E (pt) 2008-06-24
JP2009513558A (ja) 2009-04-02
WO2005013968A1 (en) 2005-02-17
IL173110A (en) 2011-04-28
DK1648440T3 (da) 2008-07-14
CA2532667A1 (en) 2005-02-17
IN229997B (enExample) 2009-03-27
MY137965A (en) 2009-04-30
AR045996A1 (es) 2005-11-23
US20050070496A1 (en) 2005-03-31
IN2006CH00198A (enExample) 2007-06-08
DE602004012413T2 (de) 2009-03-12
MX260260B (es) 2008-09-04
EP1648440B1 (en) 2008-03-12
BRPI0412759A (pt) 2006-09-26
ATE388701T1 (de) 2008-03-15
KR101143341B1 (ko) 2012-05-24
EP1498120A1 (en) 2005-01-19

Similar Documents

Publication Publication Date Title
EP0977562B1 (en) Methods and compositions for delivery of taxanes
US20090069411A1 (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
EP1267831B1 (en) New self emulsifying drug delivery system
CN1826110B (zh) 用于口服施用紫杉烷类的半固体制剂
Goyal et al. Self microemulsifying drug delivery system: A method for enhancement of bioavailability
RU2348615C2 (ru) Эмульгирующие системы, содержащие производные азетидина
HK1091743B (en) Semi-solid formulations for the oral administration of taxoids
JP2009513560A (ja) アゼチジン誘導体を含有する半固体系
HK1089951B (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
JPH04243841A (ja) 経口投与油性製剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1091743

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1091743

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100512

Termination date: 20150715

EXPY Termination of patent right or utility model